Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Editorials

  • ·Transitions at the American Heart Journal

    Page :445

    Daniel B. Mark, Patricia Hodgson, Joan Anuels, Robert M. Califf

    
  • ·The making of an author

    Page :446-447

    Paul W. Armstrong

    

• Curriculum in Cardiology

  • ·Atrial fibrillation: A major risk factor for cognitive decline

    Page :448-456

    Dawn S. Hui, John E. Morley, Peter C. Mikolajczak, Richard Lee

    Résumé Résumé Plan Plan  

• Trial Designs

  • ·Authorship in a multicenter clinical trial: The Heart Failure—A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) Scoring System Results

    Page :457

    David J. Whellan, William E. Kraus, Dalane W. Kitzman, Bridget Rooney, Steven J. Keteyian, Ileana L. Piña, Stephen J. Ellis, Jalal K. Ghali, Kerry L. Lee, Lawton S. Cooper, Christopher M. O'Connor

    Résumé Résumé Plan Plan  
  • ·Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF)

    Page :464

    Gregory Y.H. Lip, Christoph Hammerstingl, Francisco Marin, Riccardo Cappato, Isabelle Ling Meng, Bodo Kirsch, Eolo Morandi, Martin van Eickels, Ariel Cohen

    Résumé Résumé Plan Plan  
  • ·An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

    Page :472

    C. Michael Gibson, Roxana Mehran, Christoph Bode, Johnathan Halperin, Freek Verheugt, Peter Wildgoose, Martin van Eickels, Gregory Y.H. Lip, Marc Cohen, Steen Husted, Eric Peterson, Keith Fox

    Résumé Résumé Plan Plan  
  • ·Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial

    Page :479-485

    Michael R. Jaff, Kenneth Rosenfield, Dierk Scheinert, Krishna Rocha-Singh, James Benenati, Mark Nehler, Christopher J. White

    Résumé Résumé Plan Plan  

• Cardiac Safety Research Consortium

  • ·Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium

    Page :486-495

    Philip T. Sager, Jonathan Seltzer, J. Rick Turner, Jeffrey L. Anderson, William R. Hiatt, Peter Kowey, Judith J. Prochaska, Norman Stockbridge, William B. White

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study

    Page :496

    Wei Jiang, Stephen H. Boyle, Thomas L. Ortel, Zainab Samad, Eric J. Velazquez, Robert W. Harrison, Jennifer Wilson, Cynthia Kuhn, Redford B. Williams, Christopher M. O’Connor, Richard C. Becker

    Résumé Résumé Plan Plan  
  • ·Parkinson disease and risk of acute myocardial infarction: A population-based, propensity score–matched, longitudinal follow-up study

    Page :508-514

    Huey-Wen Liang, Ya-Ping Huang, Shin-Liang Pan

    Résumé Résumé Plan Plan  
  • ·Cardiac arrest and clinical characteristics, treatments and outcomes among patients hospitalized with ST-elevation myocardial infarction in contemporary practice: A report from the National Cardiovascular Data Registry

    Page :515

    Michael C. Kontos, Benjamin M. Scirica, Anita Y. Chen, Laine Thomas, Monique L. Anderson, Deborah B. Diercks, James G. Jollis, Matthew T. Roe, NCDR

    Résumé Résumé Plan Plan  
  • ·Comparison of different interdialytic intervals among hemodialysis patients on their echocardiogram-based cardiovascular parameters

    Page :523

    Masaru Obokata, Kazuaki Negishi, Thomas H. Marwick, Koji Kurosawa, Hideki Ishida, Kyoko Ito, Tetsuya Ogawa, Yoshitaka Ando, Masahiko Kurabayashi

    Résumé Résumé Plan Plan  
  • ·Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial

    Page :531-538

    Jan H. Cornel, Renato D. Lopes, Stefan James, Susanna R. Stevens, Megan L. Neely, Danny Liaw, Julie Miller, Puneet Mohan, John Amerena, Dimitar Raev, Yong Huo, Miguel Urina-Triana, Alex Gallegos Cazorla, Dragos Vinereanu, Viliam Fridrich, Robert A. Harrington, Lars Wallentin, John H. Alexander, APPRAISE-2 Study Group

    Résumé Résumé Plan Plan  
  • ·Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients

    Page :539-548

    Bradi B. Granger, Inger Ekman, Adrian F. Hernandez, Tenita Sawyer, Margaret T. Bowers, Tracy A. DeWald, Yanfang Zhao, Janet Levy, Hayden B. Bosworth

    Résumé Résumé Plan Plan  
  • ·Copeptin is an independent predictor of diabetic heart disease and death

    Page :549

    Sofia Enhörning, Bo Hedblad, Peter M. Nilsson, Gunnar Engström, Olle Melander

    Résumé Résumé Plan Plan  
  • ·A nationwide survey on perception, experience, and expectations of hybrid coronary revascularization among top-ranked US hospitals

    Page :557

    Ralf E. Harskamp, Michael E. Halkos, Ying Xian, Molly A. Szerlip, Robert S. Poston, Stephanie L. Mick, Renato D. Lopes, Jan G. Tijssen, Robbert J. de Winter, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·A novel coronary angiography index (DILEMMA score) for prediction of functionally significant coronary artery stenoses assessed by fractional flow reserve: A novel coronary angiography index

    Page :564

    Dennis T.L. Wong, Om Narayan, Brian S.H. Ko, Darryl P. Leong, Sujith Seneviratne, Elizabeth L. Potter, James D. Cameron, Ian T. Meredith, Yuvaraj Malaiapan

    Résumé Résumé Plan Plan  
  • ·Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomography II trial

    Page :572

    James L. Januzzi, Umesh Sharma, Pearl Zakroysky, Quynh A. Truong, Pamela K. Woodard, J. Hector Pope, Thomas Hauser, Thomas Mayrhofer, J. Toby Nagurney, David Schoenfeld, W.Frank Peacock, Jerome L. Fleg, Stephen Wiviott, Peter S. Pang, James Udelson, Udo Hoffmann

    Résumé Résumé Plan Plan  
  • ·Genetic markers of repolarization and arrhythmic events after acute coronary syndromes

    Page :579

    N.J. Earle, K.K. Poppe, A.P. Pilbrow, V.A. Cameron, R.W. Troughton, J.R. Skinner, D.R. Love, A.N. Shelling, G.A. Whalley, C.J. Ellis, A.M. Richards, R.N. Doughty

    Résumé Résumé Plan Plan  
  • ·Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A

    Page :587-593

    Philippe Andre, Stéphane Schneebeli, Corinne Vigouroux, Olivier Lascols, Mathieu Schaaf, Philippe Chevalier

    Résumé Résumé Plan Plan  

• Corrigendum

  • ·Correction

    Page :594

    

• Letters to the Editor

  • ·Letter to the editor regarding the manuscript “Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBNP target on the reduction of readmission and Mortality rAtes”

    Page :e3

    Ying Chun Hu, De Hong Cao, Jue Lin Deng

    Plan Plan
  • ·Response to: Letter to the editor regarding the manuscript “Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBNP target on the reduction of readmission and Mortality rAtes”

    Page :e5

    Susan Stienen, Wouter E.M. Kok, PRIMA II investigators

    
  • ·Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

    Page :e7

    Holger Thiele, Gerhard Schuler, Franz-Josef Neumann, Jörg Hausleiter, Hans-Georg Olbrich, Bettina Schwarz, Marcus Hennersdorf, Klaus Empen, Georg Fuernau, Steffen Desch, Suzanne de Waha, Ingo Eitel, Rainer Hambrecht, Michael Böhm, Volkhard Kurowski, Bernward Lauer, Hans-Heinrich Minden, Hans-Reiner Figulla, Rüdiger C. Braun-Dullaeus, Ruth H. Strasser, Kristin Rochor, Sebastian K.G. Maier, Helge Möllmann, Steffen Schneider, Henning Ebelt, Karl Werdan, Uwe Zeymer, IABP-SHOCK II Trial Investigators